Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arne C Rodloff

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Antimicrobial Resistance and Infection Control|February 17, 2015
Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and careFantahun Biadglegne, Ulrich Sack, Arne C Rodloff
Deutsches Arzteblatt International|September 27, 2019
In ReplySebastian Wendt, Arne C Rodloff, Christoph Lübbert
Antimicrobial Agents and Chemotherapy|May 25, 2004
In vitro activity of OPT-80 against Clostridium difficileGrit Ackermann, Birgit Löffler, Daniela Adler, et al.
International Journal of Medical Sciences|September 19, 2013
Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in ethiopiaFantahun Biadglegne, Belay Tessema, Arne C Rodloff, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kineticsReiner Schaumann, Matthias Funke, Eva Janssen, et al.
The Indian Journal of Medical Research|September 16, 2014
Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in EthiopiaFantahun Biadglegne, Belay Tessema, Ulrich Sack, et al.
Plos One|December 19, 2013
Tuberculous lymphadenitis in Northern Ethiopia: in a public health and microbiological perspectivesFantahun Biadglegne, Weghata Tesfaye, Ulrich Sack, et al.
Tuberculosis (Edinburgh, Scotland)|June 17, 2014
Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from EthiopiaFantahun Biadglegne, Andargachew Mulu, Arne C Rodloff, et al.
Scientific Reports|June 2, 2023
Extended-spectrum beta-lactamases found in Escherichia coli isolates obtained from blood cultures and corresponding stool specimenNina Doerr, Nadine Dietze, Norman Lippmann, et al.
Journal of Medical Microbiology|July 15, 2005
Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed culturesReiner Schaumann, Ellie Jc Goldstein, Jochen Forberg, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Antimicrobial Resistance and Infection Control|February 17, 2015
Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and careFantahun Biadglegne, Ulrich Sack, Arne C Rodloff
Deutsches Arzteblatt International|September 27, 2019
In ReplySebastian Wendt, Arne C Rodloff, Christoph Lübbert
Antimicrobial Agents and Chemotherapy|May 25, 2004
In vitro activity of OPT-80 against Clostridium difficileGrit Ackermann, Birgit Löffler, Daniela Adler, et al.
International Journal of Medical Sciences|September 19, 2013
Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in ethiopiaFantahun Biadglegne, Belay Tessema, Arne C Rodloff, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kineticsReiner Schaumann, Matthias Funke, Eva Janssen, et al.
The Indian Journal of Medical Research|September 16, 2014
Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in EthiopiaFantahun Biadglegne, Belay Tessema, Ulrich Sack, et al.
Plos One|December 19, 2013
Tuberculous lymphadenitis in Northern Ethiopia: in a public health and microbiological perspectivesFantahun Biadglegne, Weghata Tesfaye, Ulrich Sack, et al.
Tuberculosis (Edinburgh, Scotland)|June 17, 2014
Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from EthiopiaFantahun Biadglegne, Andargachew Mulu, Arne C Rodloff, et al.
Scientific Reports|June 2, 2023
Extended-spectrum beta-lactamases found in Escherichia coli isolates obtained from blood cultures and corresponding stool specimenNina Doerr, Nadine Dietze, Norman Lippmann, et al.
Journal of Medical Microbiology|July 15, 2005
Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed culturesReiner Schaumann, Ellie Jc Goldstein, Jochen Forberg, et al.
Pageof 8